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CattleTo explore the role in viral pathogenesis of the region located between the two functional AUG (inter-AUG)
in foot-and-mouth disease virus (FMDV), we derived viruses containing transposon (tn) inserts from a
mutagenized cDNA infectious clone of FMDV (pA24-WT). Mutant viruses containing an in-frame 57-nt
transposon insertion grew at a slower rate and had a smaller plaque size phenotype than the parental virus
(A24-WT). A mutant virus containing a 51-nt deletion in inter-AUG had a similar phenotype in cell culture to
that of A24-WT. When tested by aerosol inoculation in cattle (3 animals per virus), the deletion mutant was
fully virulent as was A24-WT. Mutant viruses containing insertions in inter-AUG did not cause clinical
disease or viremia. However, viruses that partially or totally removed the tn insertion during animal infection
reverted to virulence in 2 inoculated steers. Therefore, this study identiﬁed inter-AUG as an FMDV viral
virulence determinant in cattle infected by aerosol route.
Published by Elsevier Inc.Introduction
Foot-and-mouth disease virus (FMDV) causes a highly contagious,
debilitating disease in cloven-hoofed animals with devastating
economic consequences (Grubman and Baxt, 2004). FMDV belongs
to the genus Aphthovirus within the family Picornaviridae and has a
single-stranded positive-sense RNA genome approximately 8500 nt in
length. The 1300-nt 5′ untranslated region (5′UTR) is followed by a
single long open reading frame (ORF), the 3′ untranslated region (3′
UTR), and poly(A) tail. The FMDV polyprotein processing begins by
cleavage of the leader (L) from the nascent protein chain followed by
processing of P1-2A, P2, and P3 regions. Cleavage of P1-2A yields the
structural proteins (VP1, VP2, VP3, and VP4), while processing of P2
and P3 produces the viral non-structural proteins (Grubman et al.,
1984). Translation of the viral polyprotein in picornaviruses initiates
by a cap-independent mechanism at an internal AUG located
downstream from an internal ribosome entry site (IRES) in the 5′
untranslated region (UTR). In the case of foot-and-mouth disease
virus (FMDV), there are two functional AUGs separated by 75–84
nucleotides (inter-AUG) (Beck et al., 1983; Carrillo et al., 2005; Sangar
et al., 1987). Polyprotein synthesis initiates at one of the two start
codons resulting in two forms of the L protein, named Lab and Lb, that
differ only at their N-termini but have identical proteolytic activitiesdriguez).
Inc.(Cao et al., 1995; Medina et al., 1993). Leader is a cysteine proteinase
that cleaves itself (both in trans and cis) from the polyprotein and
degrades the eukaryotic initiation factor eIF4G resulting in impair-
ment of cap-mediated mRNA translation (Devaney et al., 1988;
Strebel and Beck, 1986). It also translocates to the nucleus and
interferes with the host innate response (de Los Santos et al., 2006,
2007). In infected cells, initiation at the second AUG is strongly
favored by a selection mechanism that remains uncertain (Belsham,
1992; Cao et al., 1995; Clarke et al., 1985; Lopez de Quinto and
Martinez-Salas, 1998; Piccone et al., 1995b). The role of the inter-AUG
region is not clearly deﬁned, and of the few studies that have been
published, none have evaluated the role of this region on pathogen-
esis in a natural animal host (Andreev et al., 2007; Belsham, 1992;
Lopez de Quinto andMartinez-Salas, 1998, 1999; Piccone et al., 1995a;
Thomas et al., 1996). In fact, few viral regions containing virulence
determinants for natural hosts have been identiﬁed in FMDV
including L protease, VP1, and 3A (Brown et al., 1996; Mason et al.,
2003; Pacheco et al., 2003; Sa-Carvalho et al., 1997).
Here, we generated and characterized FMD viruses containing
insertions or deletions in the inter-AUG region. The presence of
insertions in this region resulted in changes in AUG usage for
initiation of translation, delayed protein synthesis, and delayed
growth in cultured cells. Importantly, these viruses showed a severe
attenuation in cattle inoculated by a natural aerosol route. Mutant
viruses that lost the insertion regained full virulence in cattle. These
results suggest that the region located between the two functional
AUGs contains viral determinants for FMDV virulence in cattle.
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Generation of FMDV mutants
Four A24-FMDV plasmids containing tn insertions in the region
located between the two AUG initiation codons were selected from
the plasmid library described in Materials and methods and
sequenced to conﬁrm the tn insertion site. Plasmids were named
according to the position of the insertion as follows: pA24-L1115,
pA24-L1123a, pA24-L1123b, and pA24-L1159. RNA derived from
mutant plasmids and from the parental infectious clone plasmid
(pA24) were electroporated into BHK-21 cells and the supernatants
from transfected cells were passed in BHK-αVβ6 cells until a
cytopathic effect (CPE) appeared. After four or ﬁve passages in
these cells, virus stocks were aliquoted and used in all subsequent
experiments.
Full-length genomic sequencing (inclusive of the termini) of the
four resulting viruses revealed that viruses derived from pA24-
L1115 and pA24-L1123a maintained the tn insertion and were
named A24-L1115 and A24-L1123, respectively. Virus derived from
pA24-L1159 removed the tn insertion and reverted to wild type
(WT) and was not further characterized. Virus derived from pA24-
L1123b had also removed the tn insertion along with additional 17
codons in the inter-AUG region starting at position 1094 and was
named A24-L1094del (Fig. 1). In addition to the insertions or
deletions described above, mutant viruses contained a total of four
point mutations compared with the A24-WT virus. These were at nt
positions 552 (A-G) and 1470 (T-C) in mutant A24-L1115; position
915 (T-C) in A24-L1123; and nt position 4686 (A-G) in A24-
L1094del. Mutations in the ORF (nt positions 1470 and 4686) were
both synonymous.Fig. 1. Diagram of the FMDV mutants generated by tn insertion mutagenesis. The 27-
amino acid region between the two functional initiation codons for L protein (Lb and
Lab) is shown. In-frame insertions/deletion are shown below the A24-WT sequence.
Mutants are named by the location of the insertion/deletion in pA24Cru. IRES: internal
ribosomal entry site. Domain numbering is based on a model previously proposed
(Pilipenko et al., 1989).Effect of tn insertions on in vitro translation and leader proteinase
functions
To evaluate the effect of tn insertions on viral translation, full-
length RNA transcripts derived from pA24-WT and mutant plasmids
pA24-L1115, pA24-L1123a, and pA24-L1123b were in vitro translated
in rabbit reticulocyte lysates. The translation products derived from all
mutant transcripts were indistinguishable from those produced by
pA24-WT transcripts, except that the Lb band was absent in all three
mutants. Instead, all A24-L mutants yielded a product that migrated
slower than Lb, suggesting that protein synthesis occurred at the ﬁrst
functional AUG and L contained the 19 amino acids encoded by the tn
insertion (Fig. 2A). The identity of the protein product, presumably
Lab plus 19 amino acids (Lab+19), was conﬁrmed by immunoprecip-
itation using anti-L serum (Fig. 2B). These results suggest that
insertions in the region located between the two AUG initiation
codons had no effect on the self-cleavage of L from the viral
polyprotein tested by in vitro transcription and translation (Fig. 2A).
In addition to self-cleavage, L is also responsible for cleavage of the
eukaryotic initiation factor 4G (eIF4G). In order to test their ability to
cleave eIF4G, we incubated in vitro translation products of pA24-WT
and each of the mutant plasmids with HeLa cell extracts, as a source
of eIF4G. Western blot analysis revealed that translation products
from mutant plasmids degraded intact eIF4G as well as those from
pA24-WT despite their having 19 additional amino acids in L (Fig. 2C).
Replication of A24-L mutant viruses in cell culture
A24-L mutant viruses were evaluated for their ability to form
plaques on three cell lines: BHK-21, IBRS-2, and LF-BK of hamster,
swine, and bovine origins, respectively, and secondary lamb kidney
cells (LK). Virus mutant A24-L1123 had the smallest plaque size
phenotype in all three cell lines followed by A24-L1115, whereas A24-
L1094del had A24-WT-like plaque phenotype. Interestingly, A24-
L1123 and A24-L1115 viruses failed to produce visible plaques on
secondary LK cell line at a low dilution, where the A24-WT and A24-
L1094del viruses completely destroyed the monolayer (Fig. 3A).
The growth kinetics of the A24-L mutant viruses in each of the four
cell types described above were compared to that of the A24-WT at a
low (0.01) and high (10) MOI. Viruses A24-L1123 and A24-L1115
grew slower and to a slightly lower titer than A24-WT. Differences
observed among viruses at MOI 10 were less noticeable (Fig. 3B) than
those observed at MOI 0.01. The delay was most visible at 4 hpi at the
lower MOI especially in bovine and porcine cell lines as well as in
secondary lamb cells. Consistent with the plaque phenotype results,
A24-L1094del grew similarly to A24-WT virus at both MOI tested.
Similar results were obtained at MOI 0.1 (data not shown).
Effect of inter-AUG mutations on the synthesis of viral proteins in
infected cells
To analyze viral protein synthesis, LF-BK cells were infected with
A24-L mutants or A24-WT in the presence of [35S] methionine and at
various times post-infection, equal amounts of radiolabeled proteins
were immunoprecipitated using a bovine FMDV convalescent serum
and the products examined by SDS–PAGE (Fig. 4A). Virus A24-WT
reached maximum protein expression levels by 6 hpi. Mutant virus
A24-L1115 showed a delay in protein synthesis noticeable at 5 and
6 hpi, but by 8 hpi, it showed similar protein levels as the A24-WT.
Mutant A24-L1123 showed severe delay in protein synthesis, and
even by 8 hpi, this virus had not reached the 5 hpi protein synthesis
levels of A24-WT. In contrast, mutant A24-L1094del demonstrated
protein synthesis levels similar to the A24-WT virus at 5 hpi and
thereafter (Fig. 4A).
To investigate the nature of the L protein synthesized in infected
cells, lysates from A24-WT and A24-L mutant-infected LF-BK cells
Fig. 2. Effect of the tn insertions on the autocatalytic cleavage of L from the viral polyprotein (A and B) and the cleavage of the eukaryotic initiation factor eIF4G (C). (A) In vitro
translation reactions programmed with RNA transcripts derived from pA24Cru and pA24-L mutants were carried out in rabbit reticulocyte lysates at 30 °C in the presence of [35S]
methionine. Aliquots were removed at 2 hours and analyzed by SDS–PAGE on a 12% gel. Viral-speciﬁc proteins are indicated on the left side of the panel. (B) Immunoprecipitation of
translation products from panel A using a rabbit polyclonal anti-L serum. (C) HeLa S10 was incubated overnight alone (lane 1) or with equal volumes of the indicated in vitro
translation mixes (lanes 2 to 5). Samples were analyzed by SDS–7.5% PAGE andWestern blotting done with rabbit antiserum speciﬁc for eIF4G. The position of eIF4G is indicated. (⁎)
Plasmid pA24-L1123b contains a tn insertion but mutant virus A24-L1094del recovered upon RNA transfection deleted the tn and 17 amino acids from the inter-AUG region.
154 M.E. Piccone et al. / Virology 396 (2010) 152–159were analyzed by Western blot utilizing a rabbit polyclonal anti-
leader antibody (Fig. 4B). The A24-WT virus showed a strong band
corresponding to Lb and a fainter, slower band (presumably Lab). A
similar pattern was observed for mutant A24-L1123 except that the
fainter band had slower mobility than the putative Lab protein
(presumably Lab+ 19 amino acids). In the case of mutant A24-L1115,
a single band was observed that localized between Lb and Lab
suggesting translation initiation from an additional AUG present in
the tn insertion upstream of the second AUG. Finally deletion mutant
A24-1094del showed a single strong band consistent with Lb.
Virulence in cattle
Virulence of the parental and L mutant FMD viruses was assessed
utilizing an aerosolization inoculation method that resembles natural
infection (Pacheco et al., 2008). Viral virulence was determined by
examination of clinical signs and virus growth and distribution in
relevant tissues. Aerosol inoculation of three animals with A24-WT
virus resulted in shedding of virus in saliva, viremia (in two animals),
and fever by 2 dpi with clinical signs appearing by 2–4 dpi and
reaching a high clinical score by 5–7 dpi when neutralizing antibodies
were ﬁrst detectable (Fig. 5A). An animal inoculated with A24-
L1094del showed clinical disease and viral shedding undistinguish-
able from A24-WT (not shown). In contrast, three animals inoculated
with mutant A24-L1123 did not show fever, viremia, or any clinical
signs (Fig. 5A). Animals showed delayed low-titer shedding of virus in
saliva at days 6–8 and delayed appearance of low titers of neutralizing
antibodies beginning at 7–8 dpi and 14 dpi sera from these animals
recognized viral proteins in a RIP assay (data not shown). Similarly,
one of the three animals (animal no. 763) inoculated with A24-L1115
did not show fever, virus shedding, viremia, or clinical signs and lowtiters of neutralizing antibodies were detected for the ﬁrst time at
9 dpi. The remaining two animals (animals nos. 7197 and 7203)
inoculated with A24-L1115 showed viral shedding and viremia
similar to A24-WT and delayed clinical signs starting at 5 dpi with
full-blown FMD by 5–6 dpi (Fig. 5A). Viruses recovered from the sick
animals (nos. 7197 and 7203) showed partial or total removal of the
tn insertion (Fig. 5B). Due to the lack of virus recovery from sera or
secretions of cows nos. 763, 764, 7139, and 7140, insert retention
could not be assessed for these viruses.
Tissue distribution of mutant FMDV
To assess the invasiveness of FMDV mutants, we euthanized one
animal inoculated with each virus at 24 hpi. Previous studies in our
laboratory showed that after infection using an aerosol exposure
method, FMDV replicates in the nasal-pharyngeal region (soft palate
and pharynx) and lungs before invading the blood stream and causing
secondary lesions in the mouth and feet of susceptible cattle (Pacheco
et al., 2008). Both A24-WT and A24-L1094del infected the nasophar-
ynx as well as the lung by 24 hpi. Although mutants A24-L1115 and
A24-L1123 reached the same tissues, the number of positive samples
in soft palate and pharynx was smaller and had lower viral titers than
those of A24-WT and A24-L1094del (Table 1).
Discussion
The purpose of this study was to explore the effect of disruption of
the sequence in the region located between the two AUG initiation
codons of FMDV in viral virulence both in vitro and in vivo in cattle.
The presence of two functional initiation codons is conserved among
all serotypes and subtypes of FMDV sequenced to date, although the
Fig. 3. Plaque morphology of A24-WT and A24-L mutant viruses on BHK-21, IBRS-2, LF-BK, and LK cells. (A) Cells were infected with the different viruses and after 1 hour of
adsorption, 0.6% gum tragacanth overlay was added and 48 hours later stained for plaques with crystal violet. Growth curve of A24-WT and A24-L mutant viruses in different cell
lines. (B) BHK-21, IBRS-2, LF-BK or LK cells were infected at an MOI 10 or 0.01 as described in Materials and methods. At the times indicated, cells and supernatants were frozen and
virus titers were determined on the supernatant by TCID50 assay on BHK-21 cells. Results shown are from four independent experiments; bars indicate the standard deviations.
155M.E. Piccone et al. / Virology 396 (2010) 152–159length and sequence of the region between the two initiation AUG is
somewhat variable (Carrillo et al., 2005). Little is known about the
role of this region in FMDV pathogenesis in natural hosts. Previous
studies carried out in vitro indicate that the inter-AUG region
inﬂuences codon preference with the second AUG always being
preferred (Lopez de Quinto and Martinez-Salas, 1999). In this study,
in vitro transcripts derived from A24-FMDV plasmids each containing
a 57-nt tn insertion resulted in a shift in initiation of translation from
the second AUG to the ﬁrst AUG. A previous study showed that
stabilization of a stem–loop in the inter-AUG region resulted in
decreased initiation at the second AUG (Andreev et al., 2007).
Translation of all the insertion mutant transcripts showed a larger
form of the L protein, indicating that initiation at the second AUG was
either abrogated or greatly diminished. This contrasts previous
reports where changes in the inter-AUG region decreased but never
abrogated initiation from the second AUG (Andreev et al., 2007; Lopez
de Quinto and Martinez-Salas, 1999).
The insertions did not interrupt the viral ORF but introduced 19
additional codons at the L protein amino terminus. These L proteins
containing 19 amino acids of variable sequence were all functional, as
evidenced by their ability to cleave themselves from the FMDV
polyprotein and also the eIF4G ribosomal subunit, a well-described
mechanism of FMDV pathogenesis (Chinsangaram et al., 2001, 1999).
Our data showed that an additional 19-amino acid insertion in Lab
does not interfere with the proteolytic functions of in vitro produced
leader protease.Previous studies and our data described above were done in vitro
in the absence of infectious virus. The fact that our insertion
mutagenesis study was done using a full-length FMDV infectious
cDNA allowed us the recovery of infectious virus. Analysis of viral
protein synthesis in infected cells showed that the presence of
insertions in A24-L1115 and A24-L1123 resulted in delayed protein
synthesis. This delay was most severe in A24-L1123 which even by
8 hpi had not reached the 5 hpi level of protein synthesis of the WT
virus. This delay in viral protein synthesis is consistent with delays
observed in the one-step growth curves. On the other hand deletion
mutant A24-L1094del showed levels of protein synthesis and growth
similar to the WT virus. This ﬁnding is hard to explain as few reports
that characterize in vitro growth of FMDV-containing mutations in the
inter-AUG region exist. But a previous report described a tissue
culture-generated FMDV mutant with a deletion in the inter-AUG-
region that was associated to ﬁtness gain (Escarmis et al., 1999).
Analysis of the L proteins produced by the mutant viruses, as
determined by reactivity of infected cell lysates with L speciﬁc
antibodies in Western blot, showed that A24-L1115 had a single L
protein with slower mobility than the WT Lb. This slower-moving L is
likely the product of initiation at an AUG introduced by the tn
insertion upstream from AUG2. This suggests that the presence of the
additional 57 nt in this virus resulted in decreased initiation of
translation from the second functional AUG. This change in initiation
codon preference is consistent with a previous report showing that
introduction of a new AUG upstream resulted in decreased translation
Fig. 4. Effect of tn insertions on the synthesis of viral proteins in infected cells. (A) LF-BK, cells were infected with A24-WT or A24-L mutant viruses at MOI 10 and radiolabeled with
[35S] methionine for 1 hour at 5, 6, 7, and 8 hours post-inoculation (hpi). Equal amounts of radiolabeled protein were immunoprecipitated with bovine convalescent serum. The
position of speciﬁc viral proteins is indicated. (B) For Western blotting, LF-BK cells were infected with A24-WT or A24-L mutant viruses and cytoplasmic extract were prepared after
24 hpi. Equal volumes of cell extracts were resolved by 12% SDS–PAGE, transferred to nitrocellulose membranes and revealed using rabbit polyclonal anti-L serum (top) or mouse
monoclonal anti-tubulin antibody as loading control (bottom).
Fig. 5. Virulence of A24-WT and A24-L mutant viruses in cattle. (A) Three animals were inoculated with an aerosol containing 107 TCID50 and monitored for 9 days post-infection.
Saliva and serum samples were collected daily and tested for the presence of virus and/or neutralizing antibodies against FMDV. Viremia (■), virus in saliva (▴), and serum-
neutralizing antibodies titers (X) are expressed in the left axes; the clinical score (bars) based on the presence of vesicle(s) in the four feet and mouth/tongue are expressed in the
right axes. (+) denotes fever (N40 °C) detected that day. (⁎) denotes virus isolated from saliva on that day only after blind passages. Mutant A24-L1094del virus showed a disease
pattern similar to that of the A24-WT virus (data not shown). (B) Amino acid sequences of viruses recovered from animals inoculated with mutant A24-L1115.
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Table 1
Distribution of foot-and-mouth disease virus in tissues obtained from cattle 24 hours post-infection.
Tissue samplea A24-WT A24-L1094del A24-L1115 A24-L1123
vRNAb Virus infectivityc vRNA Virus infectivity vRNA Virus infectivity vRNA Virus infectivity
Pharynx
Anterior dorsal soft palate 4.84 Pos 5.11 1.75 Neg Neg Neg Pos
Posterior dorsal soft palate 3.85 2.5 6.49 4 6.45 2 3.93 2.5
Anterior dorsal nasopharynx 6.14 Pos 6.89 Neg 5.61 Neg 6.62 Neg
Posterior dorsal nasopharynx 5.12 2.5 4.63 3.25 Neg 1.75 Neg 2.5
Lung
Primary bronchus 5.77 1.75 5.51 Pos 4.49 Neg Neg Neg
Anterior lobe, distal 7.81 3.5 6.56 3.5 4.78 2 4.65 2.25
Medial lobe, distal 6.11 2.5 8.39 4 6.14 2.25 5.06 2
Posterior lobe, distal 7.48 1.75 4.69 Pos 5.63 2 5.66 Pos
a One animal was infected with each virus, and after euthanasia, tissues were collected for virus isolation and viral RNA detection.
b Viral RNA (vRNA) was quantitated by real-time RT–PCR as previously described. Values were expressed as RNA copies per milliliter of tissue macerate (Pacheco et al., 2008).
c Virus infectivity was determined in BHK-21 cells with a sensitivity of 1.75 log10 TCID50/ml.
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mutant A24-L1123 and the WT virus, there were two L protein bands,
one corresponding to Lb and a slower band likely the product of
initiation of translation from the ﬁrst AUG (Lab). The mobility of this
band in themutant virus is consistentwith a Lab protein containing an
additional 19 amino acids. It is remarkable that this mutant despite
having an additional 57 nt in the inter-AUG region initiated
translation at both functional AUGs. Although not the focus of this
article, our results are consistent with previous in vitro studies
(Andreev et al., 2007; Belsham, 1992) indicating that the structure of
the inter-AUG region is critical for initiation of translation for FMDV.
Clinical results showed that the presence of the insertion in the
inter-AUG region had a strong attenuating effect on the viruses that
retained the tn insertion (A24-1115 and A24-1123). Animals
inoculated with these viruses not only did not show fever or any
other clinical signs of FMD but also had nondetectable levels of
infectious virus in their blood and little to nondetectable viral
shedding in saliva for 1–2 days. This is in contrast with A24-WT
inoculated animals that showed full-blown FMD clinical signs
including fever, viremia, and large amounts (4–5 log10 TCID50 per
ml) of viral shedding in saliva. Previous studies showed that FMDV
lacking the leader protein was attenuated in cattle and that the
possible mechanism of attenuation was based on the inability of
leaderless virus to shut down the host cap-mediated translation and
inhibit the host innate response (Brown et al., 1996; de Los Santos et
al., 2006). In our L insertion mutants, this might not be the case as the
full-length leader protein was present in the attenuated viruses.
Two animals inoculated with A24-1115 showed full-blown FMD
although delayed by 1 day compared to theWT virus. Virus recovered
from lesions in these animals had in one case completely removed the
insertion and reverted to WT and in another case removed all but
seven amino acids of the tn insertion. In both cases, these spontaneous
revertants regained their virulence and presented clinical signs,
viremia, and viral shedding undistinguishable from the WT virus
suggesting that the presence of the insert was an attenuating factor.
Interestingly, one animal inoculated with mutant A24-1094del
showed clinical disease undistinguishable from A24-WT despite
having only 30 nt in the inter-AUG region, demonstrating that these
30 nt are sufﬁcient to carry out the functions of the inter-AUG region
for pathogenesis in vivo.
Tissue distribution 24 hours after aerosol inoculation of WT and
mutant viruses showed that the attenuated viruses reached the same
primary replication sites in pharynx and lung as the WT virus.
However, the level of infection in these tissues was lower for the
insertion-containing mutants (A24-L1115 and A24-L1123). This
result suggests that rather than differences in tropism between the
WT and attenuated viruses, virus–host interactions at primary
replication sites determined the clinical outcome of the viral infection.The mechanism of attenuation of viruses with insertions in the inter-
AUG region is currently under investigation but it is possible that the
presence of an additional 57 nt in this region resulted in delays in viral
replication and allowed the host to control the infection before
generalization occurred. Other potential mechanisms of attenuation
include lower efﬁciency to recognize the initiation codons or
inefﬁcient recruitment of ribosomal subunits to initiate translation
due to changes in the stem–loop structure in the inter-AUG region.
This is plausible and would be consistent with our observed lower
efﬁciency in translation both in vitro and in cells infected with tn-
containing mutants.
In conclusion, we have shown the inter-AUG region of FMDV
contains viral virulence determinants in cattle. Further studies are in
progress to better deﬁne the molecular mechanisms involved in viral
attenuation. Mutant viruses generated in this study could be useful
tools in understanding early interactions of FMDV with its relevant
hosts.
Materials and methods
Cells and viruses
Wild-type FMDV and viral mutants containing single in-frame
insertions or deletions in the region located between the two
functional initiation codons were derived from a plasmid encoding
the complete FMDV A24 Cruzeiro genome (pA24-WT) (Rieder et al.,
2005). In order to maintain adequate bovine receptor usage, virus
stocks were grown in a derivative of baby hamster kidney (BHK-21
ATCC catalogue no. CCL-10) cells expressing the bovine αVβ6 integrin
(BHK-αVβ6) (Duque et al., 2004) and titrated on BHK-21 cells by
calculating the 50% tissue culture infectious dose per ml (TCID50/ml).
In vitro phenotypewas characterized by plaque assays in BHK-21 cells,
a bovine kidney cell line (LF-BK) (Swaney, 1988), a porcine kidney cell
line (IBRS-2), and secondary lamb kidney cells (LK) (House and
House, 1989). Plaques were evidenced by staining monolayers at
48 hours using crystal violet as previously described (Chinsangaram
et al., 1999; Piccone et al., 1995a).
Construction of transposon-containing FMDV mutants
To identify virulence determinants within the FMDV genome, we
constructed a library of infectious FMDV full-length genome plasmids
of (pA24-WT) containing single random insertions (1 per genome),
using the EZ-Tn5™ In-Frame Linker Insertion kit (Epicentre Bio-
technologies, Madison, WI). Brieﬂy, pA24-WTwas subjected to a one-
step in vitro reaction to introduce a single EZ-Tn transposon,
containing a kanamycin resistance marker ﬂanked by NotI restriction
sites. The product of the transposition reaction was transformed into
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plated on kanamycin selection plates. Approximately 1050 colonies
were picked, and the exact location of each tn was determined by
sequencing using a pair of tn-speciﬁc primers to yield the sequence
from each tn and its ﬂanking regions. Once clones were chosen, the
kanamycin resistance gene was excised from the tn by NotI digestion.
Each NotI-digested clone was then ligated and transformed into DH5
E. coli. The resulting clones each contained a single, random 19-codon
in-frame insertion.
Plasmids derived from pA24-WT containing an insertion between
the ﬁrst (residues 1078–1080) and the second AUG (residue 1162–
1164) initiation codons were selected for further study. These
plasmids each contained an insertion at residue 1115, 1123 (2), and
1159 and were named pA24-L1115, pA24-L1123a, pA24-L1123b, and
pA24-L1159, respectively. All nucleotide designations are based on
the sequence of A24-WT (Rieder et al., 2005).
T7 RNA transcripts of SwaI-linearized pA24-L1115, pA24-L1123a,
pA24-L1123b, pA24-L1159, and pA24-WT were produced using a
MegaScript kit (Ambion, Austin, TX) and transfected into BHK-21 cells
by electroporation as described previously (Piccone et al., 1995a;
Rieder et al., 1993). Mutant viruses obtained from these transfections
were named according to the site of insertion (or deletion), namely
pA24-L1115 yielded virus A24-L1115 and pA24-L1123a yielded A24-
L1123. However, pA24-L1123b yielded a virus containing a 51-
nucleotide deletion starting at nucleotide 1094 and was named A24-
L1094del. Both the parental plasmid and pA24-L1159 yielded WT
virus named A24-WT. Virus stocks were prepared and the complete
viral genome sequence was determined.
Genome sequencing
Extractedviral RNAwas reverse-transcribedwithequimolar amounts
of random hexamers (Invitrogen) and a 3′RACE adapter primer
(Invitrogen, Carlsbad, CA) using M-MLV reverse transcriptase (Invitro-
gen, Carlsbad, CA) according to manufacturer's instructions. The 5′
terminus was determined using the 5′ RACE System for Rapid
Ampliﬁcation of cDNA Ends, Version 2.0 (Invitrogen, Carlsbad, CA) as
per themanufacturer's instructions. Theviral genomewasPCR-ampliﬁed
in eight overlapping fragments using A24-WT speciﬁc primers (primer
sequences available fromthe authors upon request). PCR fragmentswere
visualized, puriﬁed, and sequenced as previously described (Rainwater-
Lovett et al., 2007). SEQUENCHER software v4.1 (Gene-Codes, AnnArbor,
Michigan, USA) was used to analyze the chromatograms.
Virus growth and metabolic labeling
To characterize in vitro growth, BHK-21, IBRS-2, LF-BK and LK cells
were infected for 1 hour at multiplicities of infection (MOI) of 10 and
0.01 as indicated in the ﬁgure legends, washed with PBS morpholi-
neethanesulfonic acid (MES) buffer (pH 6) to inactivate unadsorbed
virus, and incubated at 37 °C. At indicated times post-infection, cells
were harvested, and virus was released from the cells by one freeze/
thaw cycle, and the titer of the clariﬁed supernatant was determined
by TCID50 as described above.
For metabolic labeling, infected cells, grown in six-well plates,
were labeled from 5 to 8 hours post-infection (hpi) with [35S]
methionine (New England Nuclear, Waltham, MA) as previously
described (Piccone et al., 1995a). Cells were lysed by adding 1%
sarcosyl and clariﬁed by centrifugation, and sampleswere analyzed by
radioimmunoprecipitation (RIP) analysis as described below.
In vitro translation and RIP analysis
In vitro translation reactions were performed with the rabbit
reticulocyte lysate (Ambion) in the presence of [35S] methionine
essentially as described by the manufacturer. Equal numbers oftrichloroacetic acid-precipitable counts from in vitro translation reac-
tions or infected cells were immunoprecipitated with bovine convales-
cent sera using ﬁxed Staphylococcus aureus bacteria, analyzed by SDS–
PAGEusing a 12%polyacrylamide gel andvisualized by autoradiography.
Western blot analysis
The ability of theWT ormutants L proteins to cleave the eukaryotic
initiation factor 4G (eIF4G) was tested as previously described
(Piccone et al., 1995b). Brieﬂy, an S10 extract of HeLa cells was
incubated at 30 °C overnight with in vitro translation products from
WT or mutants pA24-FMDV. Samples were resolved in a SDS–7.5%
PAGE and transferred to a PVDF membrane. Cellular eIF4G was
detected using eIF4G1 antibody (1:1000 dilution) (GeneTex Inc, San
Antonio, TX) and peroxidase-labeled anti-rabbit antibodies (Invitro-
gen, Carlsbad, CA).
For the detection of leader protein, LF-BK cells were infected at low
MOI and at 24 hpi, cell lysates were prepared and fractionated on a
12% SDS–PAGE, blotted, and probed with a rabbit polyclonal anti-
leader antibody (kindly provided by Marvin Grubman, ARS). An
antitubulin monoclonal antibody (MAb) was purchased from Lab
Vision. Western blots were visualized using the WesternBreeze
Chemoluminescent Immunodetection System (Invitrogen).
Virulence studies in cattle
Cattle experiments were performed under biosafety level 3 in the
animal facilities at PIADC following a protocol approved by the
Institutional Animal Use and Care Committee. Steers (300–400 kg)
were infected using an aerosolization method that resembles natural
infection (Pacheco et al., 2008). Brieﬂy, animals were sedated and
inoculatedwith 107 TCID50 in 2 ml of MEM delivered by aerosol with a
jet nebulizer (Whisper Jet, Marquest Medical Products, CO) attached
to an aerosol delivery system (Equine Aeromask, Medium Size,
Trudell Medical, London, Ontario, Canada). Three steers were
inoculated and held in individual animal rooms for each virus (A24-
WT, A24-L1115, and A24-L1123). Animals were clinically examined
daily and rectal temperature monitored for 9 days post-inoculation
(dpi). Serum and oral swabs were collected and cows were sedated
daily for clinical evaluation. Clinical scores were determined by
scoring 1–4 points for the mouth and each foot depending on the
number and size of vesicles observed for a maximum clinical score of
20. Animals that developed FMD were humanely euthanized at 9 dpi
and animals not showing clinical signs were observed for 13–15 days
before euthanasia. One additional animal for each virus mentioned
above and for A24-L1094del was similarly inoculated and euthanized
at 24 hpi. Oral and nasal swabs and serum samples were collected at 0,
6, and 24 hpi for each animal. After postmortem examination, tissues
were collected to evaluate virus distribution by virus isolation and
real-time reverse transcription PCR (RT–PCR) as previously described
(Pacheco et al., 2008). Eight tissue samples were collected including
soft palate, nasopharynx, and lung. Approximately 30 mg was
collected from each anatomical region and frozen immediately in
liquid nitrogen. Samples were stored at −70 °C until processed. The
presence or absence of each mutation was conﬁrmed by RT–PCR
sequencing on viruses isolated from animals.
Virus, viral RNA, and antibody detection
Virus isolation and viral RNA detection from tissues were
performed in BHK-21 cells as previously described (Pacheco et al.,
2008). Viral titration in swabs and sera was done as described above
and expressed in TCID50/ml. Neutralizing antibody titers were
determined as previously described (Golde et al., 2005). Sera were
also tested for the presence of antibodies against viral proteins by a
RIP assay as previously described (Piccone et al., 1995a).
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